Lessons from phase III-trials on the hormonal treatment of prostatic cancer. I: Results of EORTC-trials 30761 and 30762.
作者信息
de Voogt H J, Pavone-Macaluso M, Smith P H, de Pauw M, Suciu S
机构信息
Department of Urology, Free University Hospital, Amsterdam, Netherlands.
出版信息
Prog Clin Biol Res. 1988;260:111-7.
PMID:2966403
Abstract
摘要
相似文献
1
2
3
4
5
The EORTC Phase III trials in prostatic cancer.
Prog Clin Biol Res. 1985;185A:243-9.
6
Is there a best endocrine management of prostatic carcinoma?
Prog Clin Biol Res. 1988;269:147-58.
7
Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer: final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urological Group.己烯雌酚、醋酸环丙孕酮和醋酸甲羟孕酮治疗晚期前列腺癌的比较：欧洲癌症研究与治疗组织泌尿学组一项随机III期试验的最终分析
J Urol. 1986 Sep;136(3):624-31. doi: 10.1016/s0022-5347(17)44996-2.
8
Hormonal therapy of advanced prostatic cancer.晚期前列腺癌的激素治疗
J Urol. 1986 Sep;136(3):653-4. doi: 10.1016/s0022-5347(17)45005-1.
9
Hormonal therapy trials in prostatic cancer. An EORTC Genitourinary Group study.前列腺癌的激素治疗试验。一项欧洲癌症研究与治疗组织泌尿生殖系统组的研究。
Am J Clin Oncol. 1988;11 Suppl 2:S156-9. doi: 10.1097/00000421-198801102-00037.
10
Results of a Dutch trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer and results of EORTC studies in prostatic cancer.
Am J Clin Oncol. 1988;11 Suppl 1:S33-5.
引用本文的文献
1
Combining radiation therapy and androgen deprivation for localized prostate cancer-a critical review.局部前列腺癌的放射治疗与雄激素剥夺治疗联合应用——批判性评价。
Curr Oncol. 2010 Oct;17(5):28-38. doi: 10.3747/co.v17i5.632.
Zotero 插件